Department of Epidemiology and Biostatistics, School of Public Health, Tianjin Medical University, Tianjin, PR China; Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin, PR China.
Department of Gynecological Oncology, Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, PR China.
Gynecol Oncol. 2020 May;157(2):536-541. doi: 10.1016/j.ygyno.2020.01.039. Epub 2020 Mar 13.
To compare quality of life (Qol) of patients with stage IB2-IIA cervical cancer treated by neoadjuvant treatments followed by radical surgery (NTS) or standard chemoradiation (CRT).
Patients with stage IB2-IIA cervical cancer during 2006-2012 were treated with NTS or CRT and were invited to participate. The Functional Assessment of Cancer Therapy-Cervix (FACT-Cx) Questionnaire was used to assess patient Qol. A multivariable linear regression analysis was performed to identify factors associated with Qol.
In total, 90 (78.3%) out of 115 eligible patients completed the questionnaires. No significant differences were found in Qol between treatment groups, except that patients after NTS reported higher scores in the social/family well-being (e.g. satisfaction with sexual life, close relationships with partner or friends, and support from friends) than those after CRT, in particular, during 2-3 years after treatment. Results of multivariate analysis indicated that NTS was associated with better social/family functioning, while advanced stage of cervical cancer, lower family income and lower education were associated with impaired Qol in different domains.
Although self-reported Qol after treatment were not significantly different, NTS treated patients reported better social/family functioning than CRT treated patients, such as satisfaction with their sexual life and close relationships with partner or friends, during 2-3 years post treatment. These results were helpful for physicians to make treatment decisions while considering treatment-related Qol, and moreover, for rehabilitation and supportive care of patients after treatment. Further validation of our findings in randomized, controlled clinical trials is warranted.
比较新辅助治疗后行根治性手术(NTS)与标准放化疗(CRT)治疗的 IB2-IIA 期宫颈癌患者的生活质量(Qol)。
选择 2006-2012 年期间接受 NTS 或 CRT 治疗的 IB2-IIA 期宫颈癌患者,并邀请其参与研究。采用宫颈癌功能评估量表(FACT-Cx)评估患者的 Qol。采用多变量线性回归分析确定与 Qol 相关的因素。
共纳入 115 例符合条件的患者,其中 90 例(78.3%)完成了问卷调查。两组患者的 Qol 无显著差异,但 NTS 组患者在社会/家庭幸福感方面(如对性生活的满意度、与伴侣或朋友的亲密关系、朋友的支持)的评分高于 CRT 组,尤其是在治疗后 2-3 年。多变量分析结果表明,NTS 与更好的社会/家庭功能相关,而宫颈癌晚期、家庭收入低和受教育程度低与不同领域的 Qol 受损相关。
尽管治疗后自我报告的 Qol 无显著差异,但 NTS 组患者报告的社会/家庭功能比 CRT 组患者更好,如对性生活和与伴侣或朋友的亲密关系的满意度,在治疗后 2-3 年。这些结果有助于医生在考虑治疗相关 Qol 的同时做出治疗决策,并且有助于患者在治疗后的康复和支持性护理。需要进一步的随机对照临床试验来验证我们的研究结果。